Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 1, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc.
| -46.57K |
$1.58 | -$73,580.60 | -2.23% | 2.04M |
Feb 29
| |||||||
Akebia Therapeutics, Inc.
| -37.73K |
$1.52 | -$57,354.16 | -1.77% | 2.09M |
Feb 27
| |||||||
Akebia Therapeutics, Inc.
| 557.01K |
$1.68 | -$78,101.52 | +35.44% | 2.13M |
Jan 31 - Feb 1
| |||||||
Zynerba Pharmaceuticals, Inc.
| -80.77K |
—
|
—
| -100.00% |
0
|
Oct 10
| |||||||
Zynerba Pharmaceuticals, Inc.
| 47.71K |
$0.35 | -$40.03 | +144.33% | 80.77K |
Jun 13 - Jun 14
| |||||||
Akebia Therapeutics, Inc.
| -91.87K |
$0.88 | -$80,614.17 | -5.53% | 1.57M |
Mar 1
| |||||||
Akebia Therapeutics, Inc.
| -38.63K |
$0.81 | -$31,415.54 | -2.27% | 1.66M |
Feb 27
| |||||||
Akebia Therapeutics, Inc.
| 293.13K |
—
|
—
| +20.84% | 1.7M |
Jan 31
| |||||||
Zynerba Pharmaceuticals, Inc.
| 23.06K |
$1.01 | -$53.53 | +230.56% | 33.06K |
Jun 14
| |||||||
Akebia Therapeutics, Inc.
| 214.1K |
$2.17 | -$171,143.40 | +18.00% | 1.4M |
Feb 28 - Mar 1
| |||||||
Akebia Therapeutics, Inc.
| 1.25K |
—
|
—
| +0.33% | 375.87K |
Dec 12
| |||||||
Zynerba Pharmaceuticals, Inc.
| 5K |
—
|
—
| +100.00% | 10K |
Aug 3
| |||||||
Akebia Therapeutics, Inc.
| -4.11K |
$3.40 | -$13,970.60 | -0.36% | 1.15M |
Apr 1
| |||||||
Akebia Therapeutics, Inc.
| 39.52K |
—
|
—
| +3.54% | 1.16M |
Mar 16
| |||||||
Akebia Therapeutics, Inc.
| 187.41K |
$3.40 | -$169,771.04 | +20.17% | 1.12M |
Feb 26 - Mar 1
| |||||||
Zynerba Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Akebia Therapeutics, Inc.
| 237.4K |
—
|
—
| +30.08% | 1.03M |
Feb 28
| |||||||
Akebia Therapeutics, Inc.
| 50K |
$3.44 | $172,000.00 | +5.97% | 887.73K |
Nov 20
| |||||||
Zynerba Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Akebia Therapeutics, Inc.
| 287K |
$0.47 | $134,890.00 | +52.25% | 836.23K |
Jun 3
| |||||||
Akebia Therapeutics, Inc.
| 239.5K |
—
|
—
| +63.89% | 614.38K |
Feb 28
| |||||||
Akebia Therapeutics, Inc.
| -135.70K |
$8.94 | -$1,213,131.18 | -26.59% | 374.62K |
Dec 12
| |||||||
Zynerba Pharmaceuticals, Inc.
| 5K |
$6.43 | $32,153.00 |
∞
| 5K |
Aug 22
| |||||||
Akebia Therapeutics, Inc.
| 100K |
$0.47 | $47,000.00 | +24.37% | 510.31K |
Jul 11
| |||||||
Zynerba Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Zynerba Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 12
| |||||||
Zynerba Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Akebia Therapeutics, Inc.
| 88.9K |
—
|
—
| +27.79% | 408.81K |
Feb 28
| |||||||
Keryx Biopharmaceuticals Inc
| 10K |
—
|
—
| +100.00% | 20K |
Jun 9
| |||||||
Akebia Therapeutics, Inc.
| 119.5K |
—
|
—
| +60.27% | 317.78K |
Feb 21
| |||||||
Akebia Therapeutics, Inc.
| 20K |
$0.47 | $9,400.00 | +5.66% | 373.48K |
Jan 19
| |||||||
Relypsa Inc
| -5.10K |
$32.00 | -$163,168.00 | -100.00% |
0
|
Sep 1
| |||||||
Relypsa Inc
| 2.25K |
—
|
—
| +78.98% | 5.1K |
Jun 21
| |||||||
Relypsa Inc
| -1.01K |
$19.32 | -$19,570.35 | -26.23% | 2.85K |
Jun 7
| |||||||
Keryx Biopharmaceuticals Inc
| 10K |
—
|
—
|
∞
| 10K |
May 26
| |||||||
Keryx Biopharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Akebia Therapeutics, Inc.
| 125.5K |
—
|
—
| +55.61% | 351.17K |
Feb 22
| |||||||
Akebia Therapeutics, Inc.
| 25K |
$0.47 | $11,750.00 | +12.46% | 225.67K |
Jan 15
| |||||||
Keryx Biopharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Relypsa Inc
| -1.10K |
$34.62 | -$38,086.51 | -22.17% | 3.86K |
Jun 11
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.